Trials / Completed
CompletedNCT02135835
A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure
A Multicentre, Parallel-Group, Randomised, Double-Blind Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 365 (actual)
- Sponsor
- China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Shenfu Zhusheye in patients with acute heart failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Shenfu Zhusheye | |
| DRUG | 5% glucose injection |
Timeline
- Start date
- 2014-09-03
- Primary completion
- 2017-03-24
- Completion
- 2017-03-24
- First posted
- 2014-05-12
- Last updated
- 2018-03-01
Locations
25 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02135835. Inclusion in this directory is not an endorsement.